| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
EHD2 |
EHD2, PAST2: EH domain-containing protein 2 |
0.263 |
Evidence |
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
TAGLN |
TAGLN, SM22, WS3-10: Transgelin |
0.263 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
SORL1 |
SORL1: Sortilin-related receptor precursor |
0.263 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.263 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.263 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.263 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
TAF10 |
TAF2A, TAF10, TAF2H, TAFII30: Transcription initiation factor TFIID subunit 10 |
0.263 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.263 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
0.263 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.263 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
MYH9 |
MYH9: Myosin-9 |
0.263 |
Evidence |
|
| EEF2 |
EEF2, EF2: Elongation factor 2 |
YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
0.263 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
0.263 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
ETF1 |
ETF1, ERF1, RF1, SUP45L1: Eukaryotic peptide chain release factor subunit 1 |
0.263 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
PSMC1 |
PSMC1: 26S protease regulatory subunit 4 |
0.263 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
0.263 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
HRB2 |
KRR1, HRB2: KRR1 small subunit processome component homolog |
0.263 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
0.263 |
Evidence |
|
| FURIN |
FURIN, FUR, PACE, PCSK3: Furin precursor |
MMP11 |
MMP11, STMY3: Stromelysin-3 precursor |
0.263 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
0.263 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
MFAP4 |
MFAP4: Microfibril-associated glycoprotein 4 precursor |
0.263 |
Evidence |
|
| SPARC |
SPARC, ON: SPARC precursor |
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
0.263 |
Evidence |
|
| CD63 |
CD63, MLA1, TSPAN30: CD63 antigen |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.263 |
Evidence |
|
| HCK |
IPI00029769 |
SORL1 |
SORL1: Sortilin-related receptor precursor |
0.263 |
Evidence |
|
| HCK |
IPI00029769 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
0.263 |
Evidence |
|